Literature DB >> 15899208

[Delays and treatment interruptions: difficulties in administering radiotherapy in an ideal time-period].

Carmen González San Segundo1, Felipe A Calvo Manuel, Juan Antonio Santos Miranda.   

Abstract

Prescribed total radiation dose should be administered within in a specific time-frame and delays in commencing treatment and/or unplanned interruptions in radiation delivery are unacceptable because, in certain cancer sites, treatment-time prolongation can have a deleterious effect on local tumour control, and on patient outcomes. The present review evaluated the causes of initial treatment delays as well as interruptions in the scheduled radiotherapy. The literature search highlighted a significant concern in avoiding treatment-time prolongation in head and neck, cervix, breast and lung cancer. Among the causes involved in delay in radiotherapy commencement factors such as waiting lists, lack of material and human resources, and an increase complexity in planning, simulation and verification are highlighted. Most authors recommend radiotherapy commencement as soon as possible in radical (exclusive irradiation with active tumour present) and palliative situations with a maximum delay of no more than 6 to 8 weeks in the case of adjuvant radiotherapy (post-resection) programs. Interruptions during the course of treatment include: planned unit maintenance and servicing, acute patient toxicity or unexpected malfunction of linear accelerators; this last feature has the most deleterious effect on patients as well as radiotherapy practitioners. Interruptions that impact on the programmed time-course for radiotherapy needs to be compensated-for so as assure the biological equivalence in treatment efficacy with respect to cancer site and stage.

Entities:  

Mesh:

Year:  2005        PMID: 15899208     DOI: 10.1007/bf02710009

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  61 in total

1.  Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Authors:  J P Pignon; J Bourhis; C Domenge; L Designé
Journal:  Lancet       Date:  2000-03-18       Impact factor: 79.321

Review 2.  A global strategy for radiotherapy: a WHO consultation.

Authors:  A Porter; A Aref; Z Chodounsky; A Elzawawy; N Manatrakul; T Ngoma; C Orton; E Van't Hooft; K Sikora
Journal:  Clin Oncol (R Coll Radiol)       Date:  1999       Impact factor: 4.126

3.  Loss of local control with prolongation in radiotherapy.

Authors:  J F Fowler; M J Lindstrom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

4.  Idealized versus realized overall treatment times.

Authors:  P M Harari; J F Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-04-30       Impact factor: 7.038

5.  Evaluation of unplanned interruptions in radiotherapy treatment schedules.

Authors:  R D Lindberg; K Jones; H H Garner; B Jose; W J Spanos; D Bhatnagar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-04       Impact factor: 7.038

6.  Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

Authors: 
Journal:  Br J Urol       Date:  1997-02

7.  Radiation therapy for early glottic carcinoma (T1N0M0). The adverse effect of treatment interruption.

Authors:  M Chatani; Y Matayoshi; N Masaki; T Teshima; T Inoue
Journal:  Strahlenther Onkol       Date:  1997-10       Impact factor: 3.621

8.  Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.

Authors:  W Duncan; R H MacDougall; G R Kerr; D Downing
Journal:  Radiother Oncol       Date:  1996-12       Impact factor: 6.280

9.  Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control?

Authors:  D A Fein; W R Lee; R M Lanciano; B W Corn; S H Herbert; A L Hanlon; J P Hoffman; B L Eisenberg; L R Coia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-15       Impact factor: 7.038

10.  Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.

Authors:  R G Dale
Journal:  Radiother Oncol       Date:  1989-08       Impact factor: 6.280

View more
  2 in total

1.  [Health-care issues of combination treatment in patients with locally advanced head and neck tumors (reply)].

Authors:  Angel Segura Huerta; Laura Palomar Abad
Journal:  Clin Transl Oncol       Date:  2005-09       Impact factor: 3.405

Review 2.  Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites.

Authors:  Gustavo Pozo; Maria Angeles Pérez-Escutia; Ana Ruíz; Alejandro Ferrando; Ana Milanés; Eduardo Cabello; Raul Díaz; Alejandro Prado; Jose Fermin Pérez-Regadera
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.